Results 61 to 70 of about 1,200 (185)

Disautonomía cardiovascular en pacientes post COVID-19. Consulta de IPSTAUCLA, Barquisimeto, estado Lara

open access: yes, 2023
Following the COVID-19 pandemic, a new entity has emerged, the "post-COVID" syndrome, with multiple manifestations among which cardiovascular symptoms are mentioned.
Rodríguez, María   +9 more
core  

Central sympatholytic drugs.

open access: yesJournal of clinical hypertension (Greenwich, Conn.), 2012
•  Central sympatholytic drugs reduce blood pressure mainly by stimulating central α(2) -adrenergic receptors in the brainstem centers, thereby reducing sympathetic nerve activity and neuronal release of norepinephrine to the heart and peripheral circulation.
Wanpen, Vongpatanasin   +3 more
openaire   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

open access: yes
International audienceHeart failure (HF) exerts a global health burden, often complicated by polypharmacy due to the frequent coexistence of cardiovascular and non‐cardiovascular comorbidities.
Abdelhamid, Magdy   +16 more
core   +1 more source

The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.

open access: yes, 1996
1. The novel tri-aryl ethane CDP840, is a potent and selective inhibitor of cyclic AMP phosphodiesterase type 4 (PDE 4) extracted from tissues or recombinant PDE 4 isoforms expressed in yeast (IC50S: 4-45 nM).
E. Boyd   +49 more
core   +1 more source

sympatholytic

open access: yes
Citation: 'sympatholytic' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.16120 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Papel do sistema simpático na disfunção cardiovascular do choque séptico [PDF]

open access: yes, 2014
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas, Programa de Pós-Graduação em Farmacologia, Florianópolis, 2014.O choque séptico é um potente estímulo para a ativação de vários sistemas orgânicos e dentre ...
Favero, Ana Maria
core  

Cardiovascular dysautonomia in post COVID-19 patients. IPSTAUCLA consult office, Barquisimeto, Lara state

open access: yes, 2023
Following the COVID-19 pandemic, a new entity has emerged, the "post-COVID" syndrome, with multiple manifestations among which cardiovascular symptoms are mentioned.
Rodríguez, María   +9 more
core  

Monitoring of Retention "U-profiles" of Selected Substances on Pentafluorophenyl Stationary Phase

open access: yes, 2012
Charles University in Prague Faculty of Pharmacy in Hradec Králové Analytical Chemistry Department Candidate: Mgr. Michaela Havlátová Consultant: Doc. RNDr. Dalibor Šatínský, PhD.
Havlátová, Michaela
core  

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE. [PDF]

open access: yesHypertension, 2023
Mahfoud F   +14 more
europepmc   +1 more source

Conveying meaning through design in a safety critical medical system [PDF]

open access: yes, 2006
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel UniversityMedication errors account for a significant number of medical errors. Giving medications to patients is an activity that carries a high risk of error.
Lane, Rhonda Maria
core  

Home - About - Disclaimer - Privacy